CD4 and neoplasm: Notably, mice treated with the gE71-90 MHC-II-restricted minimal peptide epitope with polyI:C also controlled growth of the primary tumor which suggests a contribution of CD4+ T cells to the antitumor response (Fig. 3A, B).